Search Results for "Is Metformin Hydrochloride The Same As Metformin"

14:35 EDT 27th April 2015 | BioPortfolio

Matching Channels

None

Matching News

FDA Accepts NDA for Empagliflozin/Metformin Fixed-Dose Combination

The U.S. Food and Drug Administration (FDA) has accepted the filing of a New Drug Application (NDA) for empagliflozin plus immediate-release metformin hydrochloride fixed-dose combination, an investig...

FDA Approves Xigduo XR (dapagliflozin and metformin hydrochloride) for Type 2 Diabetes

WILMINGTON, Del., October 30, 2014 -- AstraZeneca today announced that the U.S. Food and Drug Administration has approved once-daily Xigduo XR (dapagliflozin and metformin hydrochloride extended-relea...

CHMP recommends empagliflozin / metformin hydrochloride for approval in the EU for the treatment of Type 2 Diabetes

BI and Lilly announce they have received a positive opinion from CHMP, recommending empagliflozin/metformin hydrochloride for the treatment type 2 diabetes... The post CHMP recommends empagliflozin / ...

FDA OKs Xigduo XR, a New Dapagliflozin-Metformin Combo

Xigduo XR is the first diabetes drug in the United States to combine a sodium glucose cotransporter-2 inhibitor with metformin hydrochloride extended-release. FDA Approvals

Metformin Prevents Type 2 Diabetes After Gestational Diabetes

Metformin and intensive lifestyle intervention both halt progression to diabetes among women with a history of gestational diabetes; strangely, though, metformin flops for women who didn't have GD...

Metformin: A Great Lakes Disaster?

(MedPage Today) -- Metformin contamination of Lake Michigan may endanger fish.

FDA Label May Prevent Use of Metformin in Type 2 Diabetics

Many patients with type 2 diabetes in the United States may be discouraged from taking metformin—a proven, oral diabetes medicine—because the U.S.Read more about FDA Label May Prevent U

Diabetes Drug Metformin Safe for Patients With Kidney Disease: Review

TUESDAY, Dec. 23, 2014 -- Although metformin, the popular type 2 diabetes medication, is usually not prescribed for people with kidney disease, a new analysis shows the drug may be safer for these pat...

Matching PubMed Articles

Metformin Beyond Diabetes: Pleiotropic Benefits of Metformin in Attenuation of Atherosclerosis.

Clinical studies show that metformin attenuates all-cause mortality and myocardial infarction compared with other medications for type 2 diabetes, even at similar glycemic levels. However, there is pa...

Anti-Diabetic Drug Metformin: Challenges and Perspectives for Cancer Therapy.

Metformin, a biguanide, is a commonly administered drug for the management of type 2 diabetes mellitus. The drug received a lot of recognition, when retrospective studies proved metformin-associated r...

Metformin Action: Concentrations Matter.

Metformin has been used for nearly a century and is now the most widely prescribed oral anti-diabetic agent worldwide. Yet how metformin acts remains only partially understood and controversial. One k...

Effect of Metformin on Metabolic Improvement and the Gut Microbiota.

Metformin is commonly used as the first line of medication for treatment of metabolic syndromes such as obesity and type 2 diabetes (T2D). Recently, metformin-induced changes in the gut microbiota hav...

Metformin in Cancer Treatment and Prevention.

Patients with diabetes mellitus are at increased risk of cancer development. Metformin is a well-established, effective agent for the management of type 2 diabetes mellitus. Epidemiological studies ha...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement